Wednesday, July 6, 2011


Catalog#:3751

Interleukin-32 (IL-32) was initially identified as a transcript (NK4) that is selectively expressed in lymphocytes and NK cells and whose expression is increased following activation by IL-2 . It was later re-isolated from an IL-18-treated lung carcinoma cell line and re-named IL-32 (2). IL-32 is unusual in that it does not share sequence homology with known cytokine families and is highly expressed in immune tissues, existing in at least four differentially spliced isoforms. Because treatment of human monocytic and mouse macrophage cells with IL-32 induces several proinflammatory cytokines such as TNF-alpha, IL-8 and MIP-2, and because it is also induced in human peripheral lymphocyte cells after mitogen stimulation and in epithelial cells by IFNgamma, it has been suggested that IL-32 may play a role in autoimmune and inflammatory diseases such as rheumatoid arthritis (3).

Additional Names: IL-32 (IN), Interleukin 32


Description

Left: Western blot analysis of IL-32 in Jurkat cell lysate with IL-32 antibody at (A) 2.5 and (B) 5 µg/ml.






Source:IL-32 antibody was raised against a 16 amino acid peptide from near the center of human IL-32.
Purification: Affinity chromatography purified via peptide column
Clonality and Clone: This is a polyclonal antibody.
Host: IL-32 antibody was raised in rabbit.
Please use anti-rabbit secondary antibodies.
Immunogen: Human IL-32 (Intermediate Domain) Peptide (Cat. No. 3751P)
Application: IL-32 antibody can be used for the detection of IL-32 by Western blot at 2.5 – 5 µg/ml.This antibody detects the largest isoform of IL-32.
Tested Application(s): E, WB
Buffer: Antibody is supplied in PBS containing 0.02% sodium azide.
Blocking Peptide:Cat. No. 3751P - IL-32 Peptide
Long-Term Storage: IL-32 antibody can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Positive Control:
1. Cat. No. 1205 - Jurkat Cell Lysate
Species Reactivity: H, M
GI Number: 14424787
Accession Number: AAH09401
Short Description: (IN) Interleukin 32
References

1. Dahl CA, Schall RP, He HL, et al. Identification of a novel gene expressed in activated natural killer cells and T cells. J. Immunol. 1992; 148:597-603.
2. Kim S-H, Han S-Y, Azam T, et al. Interleukin-32: a cytokine and inducer of TNF-a. Immunity 2005; 22:131-42.
3. Cagnard N, Letourneur F, Essabbani A, et al. Interleukin-32, CCL2, PF4F1 and GFD10 are the only cytokine/chemokine genes differentially expressed by in vitro cultured rheumatoid and osteoarthritis fibroblast-like synoviocytes. Eur. Cyto. Network 2005; 16:289-92.

Thursday, June 30, 2011

DNA Sequence Analysis


For over 20 years, BioSynthesis has provided custom oligonucleotide production services worldwide, including researcher at university, biotechnology and pharmaceutical institutions. We offer wide variety of oligo modifications and labelings from small discovery research scale to multi-gram ASR/cGMP for clinical diagnostic production. We offer design and synthesis of oligonucleotide primers and probes, also provides full range of DNA microarray printing, processing and analysis.

DNA Sequencing

The term DNA sequencing encompasses biochemical methods for determining the order of the nucleotide bases, adenine, guanine, cytosine, and thymine, in a DNA oligonucleotide. The sequence of DNA constitutes the heritable genetic information in nuclei, plasmids, mitochondria, and chloroplasts that forms the basis for the developmental programs of all living organisms.

Chain-termination Methods

While the chemical sequencing method of Maxam and Gilbert, and the plus-minus method of Sanger and Coulson were orders of magnitude faster than previous methods, the chain-terminator method developed by Sanger was even more efficient, and rapidly became the method of choice. The Maxam-Gilbert technique requires the use of highly toxic chemicals, and large amounts of radiolabeled DNA, whereas the chain-terminator method uses fewer toxic chemicals and lower amounts of radioactivity.

Recombinant DNA

Recombinant DNA is a man-made DNA sequence that has been assembled from other DNA sequences. They can be transformed into organisms in the form of plasmids or in the appropriate format, by using a viral vector.

IL-32 Antibody


Catalog#:3749

Interleukin-32 (IL-32) was initially identified as a transcript (NK4) that is selectively expressed in lymphocytes and NK cells and whose expression is increased following activation by IL-2 . It was later re-isolated from an IL-18-treated lung carcinoma cell line and re-named IL-32 (2). IL-32 is unusual in that it does not share sequence homology with known cytokine families and is highly expressed in immune tissues, existing in at least four differentially spliced isoforms. Because treatment of human monocytic and mouse macrophage cells with IL-32 induces several proinflammatory cytokines such as TNF-alpha, IL-8 and MIP-2, and because it is also induced in human peripheral lymphocyte cells after mitogen stimulation and in epithelial cells by IFNgamma, it has been suggested that IL-32 may play a role in autoimmune and inflammatory diseases such as rheumatoid arthritis (3).

Additional Names: IL-32 (CT), Interelukin 32

Description
Left: Western blot analysis of IL-32 in human spleen cell lysate with IL-32 antibody at (A) 5 and (B) 10 µg/ml shows two isoforms of IL-32. Below: Immunohistochemistry of IL-32 in human spleen tissue with IL-32 antibody at 10 µg/ml.




Source:IL-32 antibody was raised against a 15 amino acid peptide from near the carboxy terminus of human IL-32.
Purification: Affinity chromatography purified via peptide column
Clonality and Clone: This is a polyclonal antibody.
Host: IL-32 antibody was raised in rabbit.
Immunogen: Human IL-32 (C-Terminus) Peptide (Cat. No. 3749P)
Application: IL-32 antibody can be used for the detection of IL-32 by Western blot at 5 – 10 µg/ml.This antibody detects all isoforms of IL-32.
Tested Application(s): E, WB, IHC
Buffer: Antibody is supplied in PBS containing 0.02% sodium azide.
Blocking Peptide:Cat. No. 3749P - IL-32 Peptide
Long-Term Storage: IL-32 antibody can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Positive Control:
1. Cat. No. 1306 - Human Spleen Tissue Lysate
Species Reactivity: H, M
GI Number: 14424787
Accession Number: AAH09401
Short Description: (CT) Interleukin 32
References
1. Dahl CA, Schall RP, He HL, et al. Identification of a novel gene expressed in activated natural killer cells and T cells. J. Immunol. 1992; 148:597-603.
2. Kim S-H, Han S-Y, Azam T, et al. Interleukin-32: a cytokine and inducer of TNF-a. Immunity 2005; 22:131-42.
3. Cagnard N, Letourneur F, Essabbani A, et al. Interleukin-32, CCL2, PF4F1 and GFD10 are the only cytokine/chemokine genes differentially expressed by in vitro cultured rheumatoid and osteoarthritis fibroblast-like synoviocytes. Eur. Cyto. Network 2005; 16:289-92.

IL-31 Antibody

IL-31 Antibody

Catalog#:3747

Interleukin-31 (IL-31) is a recently discovered T-cell cytokine closely related to IL-6 type cytokines and is preferentially produced by T helper type 2 cells (1,2). IL-31 activity is mediated through the ligand-induced oligomerization of a dimeric receptor complex containing IL-31 receptor A and oncostatin M receptor (2). In response to IL-31 binding, these proteins activate the JAK/STAT and the AKT signaling pathways (3). RNA levels of IL-31 receptor A and oncostatin M receptor are induced in activated monocytes but are expressed constitutively in epithelial cells . IL-31, when overexpressed in transgenic mice, results in the development of pruritis, alopecia, and skin lesions and in humans may result in atopic dermatitis, suggesting that IL-31 may represent a novel target for antipruritic drug development (1,4).

Additional Names: IL-31 (IN), Interleukin 31, IL31


Description

Left: Western blot analysis of IL-31 in human skeletal muscle tissue lysate with IL-31 antibody at (A) 2.5, (B) 5 and (C) 10 µg/ml.






Source:IL-31 antibody was raised against a 18 amino acid peptide from near the center of human IL-31.
Purification: Affinity chromatography purified via peptide column
Clonality and Clone: This is a polyclonal antibody.
Host: IL-31 antibody was raised in rabbit.
Please use anti-rabbit secondary antibodies.
Immunogen: Human IL-31 (Intermediate Domain) Peptide (Cat. No. 3747P)
Application: IL-31 antibody can be used for the detection of IL-31 by Western blot at 2.5 – 5 µg/ml.Despite its predicted size, IL-31 runs at approximately 27 - 30 kDa in SDS-PAGE.
Tested Application(s): E, WB
Buffer: Antibody is supplied in PBS containing 0.02% sodium azide.
Blocking Peptide:Cat. No. 3747P - IL-31 Peptide
Long-Term Storage: IL-31 antibody can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Positive Control:
1. Cat. No. 1375 - Human Skeletal Muscle Tissue Lysate
Species Reactivity: H, M
GI Number: 46241139
Accession Number: AAS82846
Short Description: (IN) Interleukin 31
References
1. Dillon SR, Sprecher C, Hammond A, et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat. Immunol. 2004; 5:752-60.
2. Dreuw A, Radtke S, Pflanz S, et al. Characterization of the signaling capacities of the novel gp130-like cytokine receptor. J. Biol. Chem. 2004; 279:36112-20.
3. Diveu C, Lak-Hal AH, Froger J, et al. Predominant expression of the long isoform of GP130-like (GPL) receptor is required for interleukin-31 signaling. Eur. Cytokine Netw. 2004; 15:291-302.
4. Bilsborough J, Leung DY, Maurer M, et al. IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis. J. Allergy Clin. Immunol. 2006; 117:418-25.

IL-31 Antibody

IL-31 Antibody

Catalog#:3745

Interleukin-31 (IL-31) is a recently discovered T-cell cytokine closely related to IL-6 type cytokines and is preferentially produced by T helper type 2 cells (1,2). IL-31 activity is mediated through the ligand-induced oligomerization of a dimeric receptor complex containing IL-31 receptor A and oncostatin M receptor (2). In response to IL-31 binding, these proteins activate the JAK/STAT and the AKT signaling pathways (3). RNA levels of IL-31 receptor A and oncostatin M receptor are induced in activated monocytes but are expressed constitutively in epithelial cells . IL-31, when overexpressed in transgenic mice, results in the development of pruritis, alopecia, and skin lesions and in humans may result in atopic dermatitis, suggesting that IL-31 may represent a novel target for antipruritic drug development (1,4).

Additional Names: IL-31 (NT), Interleukin 31, IL31

Description

Left:
Western blot analysis of IL-31 in RAW264.7 cell lysate with IL-31 antibody at (A) 2.5, (B) 5 and (C) 10 µg/ml.


Below: Immunohistochemistry of IL-31 in rat skeletal muscle tissue with IL-31 antibody at 10 µg/ml.

Other Product Images
Source:IL-31 antibody was raised against a 16 amino acid peptide from near the amino terminus of mouse IL-31.
Purification: Affinity chromatography purified via peptide column
Clonality and Clone: This is a polyclonal antibody.
Host: IL-31 antibody was raised in rabbit.
Please use anti-rabbit secondary antibodies.
Immunogen: Murine IL-31 (N-Terminus) Peptide (Cat. No. 3745P)
Application: IL-31 antibody can be used for the detection of IL-31 by Western blot at 2.5 – 5 µg/ml.
Tested Application(s): E, WB, IHC
Buffer: Antibody is supplied in PBS containing 0.02% sodium azide.
Blocking Peptide:Cat. No. 3745P - IL-31 Peptide
Long-Term Storage: IL-31 antibody can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Positive Control:
1. Cat. No. 1283 - RAW264.7 Cell Lysate
2. Cat. No. 1467 - Rat Skeletal Muscle Tissue Lysate
Species Reactivity: M
GI Number: 46241139
Accession Number: AAS82846
Short Description: (NT) Interleukin 31
References

1. Dillon SR, Sprecher C, Hammond A, et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat. Immunol. 2004; 5:752-60.
2. Dreuw A, Radtke S, Pflanz S, et al. Characterization of the signaling capacities of the novel gp130-like cytokine receptor. J. Biol. Chem. 2004; 279:36112-20.
3. Diveu C, Lak-Hal AH, Froger J, et al. Predominant expression of the long isoform of GP130-like (GPL) receptor is required for interleukin-31 signaling. Eur. Cytokine Netw. 2004; 15:291-302.
4. Bilsborough J, Leung DY, Maurer M, et al. IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis. J. Allergy Clin. Immunol. 2006; 117:418-25.

Thursday, June 23, 2011

DNA Strand


Bio-Synthesis continued to provide quality DNA products and services for the research community, but it has also become a world leader in providing custom peptide products and services. We offer comprehensive services for polyclonal antibody production with large selection for host animals.

DNA Strand Hypothesis

The immortal DNA strand hypothesis was proposed in 1975 by John Cairns as a mechanism for adult stem cells to minimize mutations in their genomes. This hypothesis proposes that instead of segregating their DNA during mitosis in a random manner, adult stem cells divide their DNA asymmetrically, and retain a distinct template set of DNA strands (parental strands) in each division. By retaining the same set of template DNA strands, adult stem cells would pass mutations arising from errors in DNA replication on to non-stem cell daughters that soon terminally differentiate (end mitotic divisions and become a functional cell).

DNA Strands

In the label-retention assay, the goal is to mark 'immortal' or parental DNA strands with a DNA label such as tritiated thymidine or bromodeoxyuridine (BrdU). These types of DNA labels will incorporate into the newly-synthesized DNA of dividing cells during S phase. A pulse of DNA label is given to adult stem cells under conditions where they have not yet delineated an immortal DNA strand.

For more information visit: www.biosyn.com

IL-17 Antibody


Catalog#:4877

Interleukin 17 (IL-17) is a family of pro-inflammatory cytokines produced by activated T cells and is thought to have a major role in the initiation and perpetuation of rheumatoid arthritis. IL-17 regulates the activities of NF-kB and mitogen-activated protein kinases such as ERK and JNK. In addition, IL-17 stimulates the expression of IL-6 and cyclooxygenase-2 and enhances the production of nitric oxide. IL-17-producing T helper cells (TH-17 cells) have been the subject of much attention due to the importance of IL-17 in the pathogenesis of autoimmune inflammation. Because of its role in autoimmune diseases, it is thought that targeting the production and action of IL-17 would be beneficial therapeutically in these diseases.

Additional Names: IL-17 (NT), Interleukin-17, IL-17A, CTLA8


Description

Left: Western blot analysis of IL-17 in A-20 lysate with IL-17 antibody at (A) 2 and (B) 4 µg/ml.











Source:IL-17 antibody was raised against a 16 amino acid peptide from near the amino terminus of human IL-17A.
Purification: Affinity chromatography purified via peptide column
Clonality and Clone: This is a polyclonal antibody.
Host: IL-17 antibody was raised in rabbit.
Please use anti-rabbit secondary antibodies.
Application: IL-17 antibody can be used for the detection of IL-17 by Western blot at 2 – 4 µg/ml.
Tested Application(s): E, WB
Buffer: Antibody is supplied in PBS containing 0.02% sodium azide.
Blocking Peptide:Cat.No. 4877P - IL-17 Peptide
Long-Term Storage: IL-17 antibody can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Positive Control:
1. Cat. No. 1288 - A20 Cell Lysate
Species Reactivity: H, M
GI Number: 4504651
Accession Number: NP_002181
Short Description: (NT) Interleukin-17A
References
1. Miossec P. Are T cells in rheumatoid synovium aggressors or bystanders? Curr. Opin. Rheumatol. 2000; 12:181-5.
2. Paunovic V, Carroll HP, Vandenbroeck K, et al. Crossed signals: the role of interleukin (IL)-12, -17, -23, and -27 in autoimmunity. Rheumatol. 2008; 47:771-6.
3. Steinman L. A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell-mediated tissue damage. Nat. Med. 2007; 13:139-145.

IL-17 Antibody


Catalog#:4887

Interleukin 17 (IL-17) is a family of pro-inflammatory cytokines produced by activated T cells and is thought to have a major role in the initiation and perpetuation of rheumatoid arthritis. IL-17 regulates the activities of NF-kB and mitogen-activated protein kinases such as ERK and JNK. In addition, IL-17 stimulates the expression of IL-6 and cyclooxygenase-2 and enhances the production of nitric oxide. IL-17-producing T helper cells (TH-17 cells) have been the subject of much attention due to the importance of IL-17 in the pathogenesis of autoimmune inflammation. Because of its role in autoimmune diseases, it is thought that targeting the production and action of IL-17 would be beneficial therapeutically in these diseases.

Additional Names:
IL-17 (IN), Interleukin-17, IL-17A, CTLA8


Description

Left: Western blot analysis of IL-17 in A-20 lysate with IL-17 antibody at (A) 0.5 and (B) 1 µg/ml.











Source:IL-17 antibody was raised against a 19 amino acid peptide from near the center of human IL-17A.
Purification: Affinity chromatography purified via peptide column
Clonality and Clone: This is a polyclonal antibody.
Host: IL-17 antibody was raised in rabbit.
Please use anti-rabbit secondary antibodies.
Application: IL-17 antibody can be used for the detection of IL-17 by Western blot at 0.5 – 1 µg/ml.
Tested Application(s): E, WB
Buffer: Antibody is supplied in PBS containing 0.02% sodium azide.
Blocking Peptide:Cat.No. 4887P - IL-17 Peptide
Long-Term Storage: IL-17 antibody can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Positive Control:
1.Cat. No. 1288 - A20 Cell Lysate
Species Reactivity: H, M
GI Number: 4504651
Accession Number: NP_002181
Short Description: (IN) Interleukin-17A
References
1. Miossec P. Are T cells in rheumatoid synovium aggressors or bystanders? Curr. Opin. Rheumatol. 2000; 12:181-5.
2. Paunovic V, Carroll HP, Vandenbroeck K, et al. Crossed signals: the role of interleukin (IL)-12, -17, -23, and -27 in autoimmunity. Rheumatol. 2008; 47:771-6.
3. Steinman L. A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell-mediated tissue damage. Nat. Med. 2007; 13:139-145.

IKK gamma Antibody




Catalog#:2335

Nuclear factor kappa B (NF-kappaB) is a ubiquitous transcription factor and an essential mediator of gene expression during activation of immune and inflammatory responses. NF-kappaB mediates the expression of a great variety of genes in response to extracellular stimuli. NF-kappaB is associated with IkB proteins in the cell cytoplasm, which inhibit NF-kappaB activity. The IkB kinase (IKKalpha and IKKbeta) phosphorylates IkB and mediates NF-kappaB activation. A novel molecule in the IKK complex was recently identified and termed IKKgamma/NEMO/FIP3/IKKAP1 (1-5). IKKg interacts with IKKbeta and is required for the activation of IKK complex and NF-kappaB by LPS, PMA, TNF, and IL-1 stimulation (1-4). FIP3 was also shown to bind to RIP and NIK and to mediate TNF-induced NF-kappaB activation (3).

Additional Names: IKK gamma (CT),IKKg / NEMO, NEMO, FIP3

Description

Left:
Western blot analysis of IKK gamma in HeLa whole cell lysate with IKK gamma antibody at 1 µg/ml.


Below: Immunocytochemistry of IKK gamma in HeLa cells with IKK gamma antibody at 5 µg/ml.

Other Product Images

Source:IKK gamma antibody was raised against a peptide corresponding to amino acids 400 to 416 of human IKK gamma, which are identical to those of mouse homologue.
Purification: Affinity chromatography purified via peptide column
Clonality and Clone: This is a polyclonal antibody.
Host: IKK gamma antibody was raised in rabbit.
Please use anti-rabbit secondary antibodies.
Immunogen: Human IKK gamma Peptide (Cat. No. 2335P)
Application: IKK gamma antibody can be used for detection of IKK gamma by Western blot at 0.5 to 1 µg/ml.A 52 kDa band should be detected. IKK gamma has no cross response to IKK alpha or IKK beta.
Tested Application(s): E, WB, ICC
Buffer: Antibody is supplied in PBS containing 0.02% sodium azide.
Blocking Peptide:Cat. No. 2335P - IKK gamma Peptide
Long-Term Storage: IKK gamma antibody can be stored at 4ºC, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Positive Control:
1.Cat. No. 1201 - HeLa Cell Lysate
Species Reactivity: H, M, R
GI Number: 3641279
Accession Number: AF074382
Short Description: (CT) IkB Kinase gamma
References
1. Rothwarf DM, Zandi E, Natoli G, Karin M. IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex. Nature 1998;395(6699):297-300
2. Yamaoka S, Courtois G, Bessia C, Whiteside ST, Weil R, Agou F, Kirk HE, Kay RJ, Israel A. Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell. 1998;93(7):1231-40.
3. Li Y, Kang J, Friedman J, Tarassishin L, Ye J, Kovalenko A, Wallach D, Horwitz MS. Identification of a cell protein (FIP-3) as a modulator of NF-kappaB activity and as a target of an adenovirus inhibitor of tumor necrosis factor alpha-induced apoptosis. Proc Natl Acad Sci U S A 1999;96(3):1042-7
4. Mercurio F, Murray BW, Shevchenko A, Bennett BL, Young DB, Li JW, Pascual G, Motiwala A, Zhu H, Mann M, Manning AM. IkappaB kinase (IKK)-associated protein 1, a common component of the heterogeneous IKK complex. Mol Cell Biol. 1999;19(2):1526-38.

Wednesday, June 22, 2011

Clone Antibody



Bio-Synthesis, with 20 years of experience in developing polyclonal antibodies, is a leading global provider of custom antibody production services. Our facility generates high-affinity custom antibodies with industry-leading titer guarantees and comprehensive antibody production packages that simplify the ordering process and present cost-effective methods to isolate epitope-specific antibodies. Visit www.biosyn.com and see why partner with Bio-Synthesis for your custom antibodies needs.

Antibodies

From Antigen selection to antibody purification, BSI has optimized each step of the antibody production process to provide the best antibodies available.

Custom peptide antibody production

Keyhole Limpet Hemocyanin (KLH), Bovine Serum Albumin (BSA), Rabbit Serum Albumin (RSA), Ovalbumin, Thyroglobulin, or Human Gamma Globulin (HGG).Amino Acid Analysis of Conjugates also available.

Isotypes

Antibodies can come in different varieties known as isotypes or classes. In placental mammals there are five antibody isotypes known as IgA, IgD, IgE,IgG and IgM.The antibody isotype of a B cell changes during the cell's development and activation.









For more information visit: www.biosyn.com